Mitesco Inc,. Biotech Stock Review

Biotech Stock Review: Mitesco (MITI) $0.03, Report Update

Mitesco to Launch Telehealth Enabled Primary Care Clinic Business with Q4 Rollout Addressing Healthcare Backlog Accentuated by the Second Wave Concerns. REPORT UPDATE: Denver, CO, May...

Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double in 2020.

No Doubles Yet, But They're Doing Rather Well, Considering Everything. Our Confidence Remains Unwavered. Best Performer up 63%. IN ORDER OF SHARE PRICE..LOW TO HIGH Mitesco...

True Nature | Mitesco (MITI) Raising $15 Million.

LIVE CHART Mitesco, Inc. Announces up to $15 Million Unit Preferred Capital Raise Mitesco (formerly known as True Nature) is gaining steam since announcing they engaged...
Immunomedics IMMU, Biotech Stock Review

Immunomedics (IMMU) up 100% Today or $2 Billion in Value.

Again as mentioned a few weeks ago, our bearish market opinion is related to large-caps and large-cap funds and ETF's. If you find a small company whose...

European Hand Sanitizer Market Expected to Reach $9.4 Billion by 2027.

Growing at a CAGR of 38.4% during 2019–2027. The European hand sanitizer market was valued at US$ 641.7 million in 2018 and is expected to...

CDC’s Worst-Case Coronavirus Model: 214 Million Infected, 1.7 Million Dead (Intelligencer)

A recent CDC projection estimated that the U.S. coronavirus epidemic could infect between 160 million and 214 million people over a period of more...
American BriVision

American BriVision (ABVC) Improves Working Capital and Reduce Debt.

American BriVision Announces Two Financial Transactions to Improve Working Capital and Reduce Debt FREMONT, CA, April 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – American...

FDA Authorizes Athersys (ATHX) to Initiate a Pivotal Clinical Trial!

FDA Authorizes Athersys to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome. (Editors note: a...
Corbus Pharma, Biotech Stock Review

Adding Corbis Pharma (CRBP) $5.55 to Watch List.

Running Clinical Trials Full Steam With $46 Million Banked in Late February. Not thinly, but lightly traded. Ready, locked and loaded. All of the common...
Athersys, Biotech Stock Review

Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.

A major Wall Street firm that specializes in Bio and Medtech Companies has a $12 price target out on Athersys from one of its...

Latest article

GeoVax (GOVX) Conference Call and Transcript.

Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah. Guess what we'll choose to do? For the life...

Sekur Private Data (SWISF) Awarded Distribution Agreement With Elyon International.

Top Ranked Defense, Government and Enterprise Contractor Trying to Break Over $0.06. We are still sitting on the edge of our seat waiting for contract news,...

Broker Dealer – AtlasClear (ATCH) Conference Call

"AtlasClear is being built as an integrated financial services platform that will bring capital markets origination, clearing, and banking together under a single architecture."...